Description

Tirzepatide is a synthetic peptide that functions as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It has been studied in preclinical and clinical research for its effects on glycemic regulation, insulin sensitivity, appetite signaling, and metabolic function. Research models have explored its potential impact on weight modulation and energy balance, particularly in the context of metabolic disorders. For Research Use Only. Not intended for human consumption, medical, diagnostic, or therapeutic purposes.